CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)

Clinical trial NCT02580448 · COMPLETED

Trial details

NCT number: NCT02580448
Sponsor: Innocrin Pharmaceutical
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer of the Breast Breast Cancer Advanced Breast Cancer Metastatic Breast Cancer Male Breast Cancer Triple Negative Breast Cancer ER+ Breast Cancer

Start date: 2015-08-01
Primary completion: 2019-01-01
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.